MENU
Showcases Stock ranks Forex

Pfizer Inc (PFE)
40.02  -0.08 (-0.2%) 05-14 16:02
Open: 39.44 Pre. Close: 39.35
High: 39.92 Low: 39.305
Volume: 20,929,704 Market Cap: 223,238M
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; a material transfer and collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; and a multi-target drug discovery collaboration with Sosei Group Corporation. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 40.067 - 40.278 40.278 - 40.457
Low: 38.807 - 39.048 39.048 - 39.252
Close: 39.621 - 40.033 40.033 - 40.384
Stock Technical Analysis
Overall:     
Target: Six months: 47.99
One year: 56.06
Support: Support1: 38.15
Support2: 36.33
Resistance: Resistance1: 41.09
Resistance2: 47.99
Pivot: 39.38
Moving Averages: MA(5): 39.80
MA(20): 39.28
MA(100): 36.52
MA(250): 35.78
MACD: MACD(12,26): 0.75
Signal(12,26,9): 0.79
%K %D: %K(14,3): 63.15
%D(3): 57.54
RSI: RSI(14): 64.79
52-Week: High: 43.08
Low: 29.990513
Change(%): 10.8
Average Vol(K): 3-Month: 3033995
10-Days: 3763822
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.

PFE has closed below upper band by 22.5%. Bollinger Bands are 14.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Sat, 15 May 2021
Why Pfizer Is a Top Pick for Dividend Investors - Yahoo Finance

Wed, 12 May 2021
Pfizer Inc. stock outperforms market on strong trading day - MarketWatch

Thu, 06 May 2021
Pfizer Inc. (PFE) Stock: How Does it Score on Fundamental Metrics? - InvestorsObserver

Tue, 04 May 2021
Pfizer Inc. (PFE) is up 3.90% in a Week, Should You Accumulate? - InvestorsObserver

Tue, 04 May 2021
Pfizer (PFE) Q1 Earnings Beat, COVID-19 Vaccine Boosts Sales - Yahoo Finance

Tue, 04 May 2021
Pfizer Earnings: What Happened with PFE - Investopedia

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 5580.00
Shares Float (M) 5570.00
% Held by Insiders 0.04
% Held by Institutions 67.55
Shares Short (K) 60890
Shares Short Prior Month (K) 68320
Stock Financials
EPS 1.710
Book Value (p.s.) 11.360
Profit Margin 22.95
Operating Margin 24.17
Return on Assets (ttm) 3.9
Return on Equity (ttm) 11.1
Qtrly Rev. Growth -7.9
Gross Profit (p.s.) 5.973
Sales Per Share 7.511
EBITDA (p.s.) 2.668
Qtrly Earnings Growth
Operating Cash Flow (M) 14400.00
Levered Free Cash Flow (M) 10500.00
Stock Valuation
PE Ratio 23.40
PEG Ratio
Price to Book value 3.52
Price to Sales 5.33
Price to Cash Flow 15.51
Stock Dividends
Dividend 1.520
Dividend Yield 0.04
Dividend Growth 1.560

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator